Status | Study |
Available |
Study Name: Treatment Use of 3,4 Diaminopyridine in Congenital Myasthenia and Lambert-Eaton Syndrome Condition: Congenital Myasthenic Syndrome Lambert-Ea Date: 2017-02-21 Interventions: Drug: 3,4-Diaminopyridine The investigator will prescribe an initial dose of 3,4 diaminopyridine (DAP) b |
Recruiting |
Study Name: Phase 3 Study to Evaluate Efficacy of Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS) Condition: Lambert-Eaton Myasthenic Syndrome Date: 2016-11-16 Interventions: Drug: Amifampridine Phosphate Drug: Placeb |
Recruiting |
Study Name: Amifampridine Phosphate for the Treatment of Congenital Myasthenic Syndromes Condition: Myasthenic Syndromes, Congenital Date: 2015-09-24 Interventions: Drug: amifampridine phosphate |
Available |
Study Name: Expanded Access Study Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS), Congenital Myasthenic Syndrome (CMS), or Downbeat Nystagmus Patients Condition: Lambert-Eaton Myasthenic Syndrome Congenital Date: 2014-07-05 Interventions: Drug: Amifampridine Phosphate Dosage form: tablets contain |
Recruiting |
Study Name: National Registry for Egyptian Pediatric Neuromuscular Diseases Condition: Spinal Muscular Atrophy Muscular Dystrophy Muscle Diseases Date: 2014-04-25 |
Enrolling by invitation |
Study Name: Controlled Trial of 3,4-Diaminopyridine (3-4DAP) in Lambert-Eaton Myasthenic Syndrome (LEMS) Condition: Muscle Weakness Date: 2014-03-14 Interventions: Drug: 3-4 Diaminopyridine Other Name: 3-4 DAP |
Available |
Study Name: 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome (LEMS) and Congenital Myasthenia (CM) Condition: Lambert-Eaton Myasthenic Syndrome (LEMS) Congenital Myasthenia Date: 2013-12-11 Interventions: Drug: 3,4-diaminopyridine 10mg tablets for up to 100mg per day |
Available |
Study Name: Use of 3,4-Diaminopyridine in the Treatment of Lambert-Eaton Syndrome Condition: Lambert Eaton Myasthenic Syndrome Date: 2013-03-22 Interventions: Drug: 3, 4-Diaminopyridine |
Available |
Study Name: Treatment Use of 3,4-Diaminopyridine Condition: Lambert Eaton Myasthenic Syndrome (LEMS) Date: 2013-01-06 Interventions: Drug: 3,4-diaminopyridine Trea |
Completed |
Study Name: Pregnancy Outcomes in Congenital Myasthenie Syndrome Condition: Congenital Myasthenic Syndrome Date: 2011-11-16 |